If you no longer wish to receive these alerts, unsubscribe here.
| Liver International Volume 43, Issue 10 Pages: 2047-2333 October 2023 |
|
ISSUE INFORMATION
Issue Information
Pages: 2047-2051 | First Published: 18 September 2023
EDITORS' PERSPECTIVE
Usefulness of PNPLA3 variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk?
Pages: 2052-2054 | First Published: 18 September 2023
EDITORIALS
Autophagy in liver regeneration: Unravelling the endothelial cell's role and therapeutic prospects
Pages: 2055-2056 | First Published: 18 September 2023
Risk of severe infection in patients with non‐alcoholic fatty liver disease: Implication on clinical management
Pages: 2057-2059 | First Published: 18 September 2023
Defining recompensation of alcohol‐related liver disease: A step beyond decompensated cirrhosis
Pages: 2060-2061 | First Published: 18 September 2023
REVIEWS & META-ANALYSES
Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region
Pages: 2062-2077 | First Published: 08 August 2023
Management of alcoholic hepatitis: A clinical perspective
Pages: 2078-2095 | First Published: 22 August 2023
LIVER DISEASE AND PUBLIC HEALTH
The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study (NASH‐CO study)
Pages: 2096-2106 | First Published: 14 July 2023
Combined use of the ELF test and CLivD score improves prediction of liver‐related outcomes in the general population
Pages: 2107-2115 | First Published: 23 July 2023
VIRAL HEPATITIS
Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell‐derived hepatocytes
Pages: 2116-2129 | First Published: 27 June 2023
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort
Pages: 2130-2141 | First Published: 31 August 2023
METABOLIC & TOXIC LIVER DISEASES
Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study
Pages: 2142-2152 | First Published: 20 July 2023
Trajectories of glycaemic traits exhibit sex‐specific associations with hepatic iron and fat content: Results from the KORA‐MRI study
Pages: 2153-2166 | First Published: 03 June 2023
Non‐alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension
Pages: 2167-2176 | First Published: 13 June 2023
Persistent organic pollutants associate with liver disease in a Finnish general population sample
Pages: 2177-2185 | First Published: 13 June 2023
GUT-LIVER AXIS, IMMUNOLOGY, IMMUNE MEDIATED AND CHOLESTATIC DISEASES
Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study
Pages: 2186-2197 | First Published: 30 June 2023
